Annis Gardner Whiting Capital Advisors, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1998414
TAMPA, FL
Position in NBIX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,712
-$3,393 QoQ
Shares Held
13
-63.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Annis Gardner Whiting Capital Advisors, LLC holds $93,254 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
3,002 | $30,050 | |
| 2 | ZTS |
Zoetis Inc.
|
212 | $25,060 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,124 | $20,816 | |
| 4 | VTRS |
Viatris Inc
|
864 | $11,672 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
13 | $1,712 | |
| 6 | ASRT |
Assertio Holdings, Inc.
|
80 | $1,524 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
20 | $1,033 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
4 | $307 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,712 | 13 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,105 | 36 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,053 | 36 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,524 | 36 | Shares | Sole | 2025-08-11 | |
| 2024-06-30 | $21,476 | 156 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,998 | 145 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||